Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1245.15 today, marking a significant decline in its share price amid broader market fluctuations. The stock has underperformed its sector and key benchmarks, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Jupiter Life Line Hospitals Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a deteriorating market outlook. Despite solid operational metrics, the stock has seen a decline in price and a downgrade in its overall mojo rating, reflecting growing investor caution in the hospital sector.

Jupiter Life Line Hospitals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 17 Dec 2025, reflecting a shift from the previous Hold rating. However, the analysis and financial metrics discussed here represent the stock’s current position as of 01 February 2026, providing investors with the latest insights into its performance and outlook.

Jupiter Life Line Hospitals Ltd., a Mumbai-based hospital chain with a market capitalisation of ₹8,412 crores, reported a robust 30.67% quarter-on-quarter surge in consolidated net profit to ₹57.35 crores in Q2 FY26, up from ₹43.89 crores in Q1 FY26. On a year-on-year basis, profits grew 11.04%, demonstrating sustained momentum in the company's expansion trajectory. However, the stock has struggled to translate operational gains into market returns, declining 15.50% over the past year whilst trading at a premium valuation of 44 times trailing earnings.

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with the latest insights into its performance and outlook.

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into its performance and outlook.

Jupiter Life Line Hospitals has experienced a notable shift in its technical momentum, with recent evaluation adjustments signalling a bearish trend across multiple timeframes. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, suggests a cautious outlook for investors amid broader market dynamics.

Jupiter Life Line Hospitals has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend, reflecting potential long-term weakness in the stock’s price movement.

Jupiter Life Line Hospitals has recently undergone a revision in its evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical indicators. This comprehensive analysis explores the factors influencing the current market assessment of the hospital sector stock, providing investors with a detailed understanding of its recent performance and outlook.

Jupiter Life Line Hospitals has experienced a notable shift in its technical momentum, reflecting a transition from a sideways trend to a mildly bearish stance. This change in market assessment comes amid a backdrop of subdued price movement and mixed signals from key technical indicators, underscoring the challenges faced by the hospital sector in the current market environment.

Jupiter Life Line Hospitals has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent assessment changes in key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveal a complex picture for the hospital sector stock as it navigates current market conditions.

Jupiter Life Lin has experienced a revision in its market evaluation, reflecting changes across several key analytical parameters. The hospital sector stock, classified as a small-cap, shows a complex financial and technical profile that has influenced this shift in assessment.

Jupiter Life Line Hospitals has recently experienced a stock price adjustment amid market fluctuations, currently trading at 1,463.20. The company's performance indicators present a mixed outlook, with some showing bullish trends while others indicate bearish signals. Its returns have underperformed compared to the Sensex over various timeframes.